Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Year-over-year total asset growth rate
Latest
7.22%
↓ 96% vs avg
Percentile
P74
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
184.76%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 7.22% |
| Q3 2025 | 2.55% |
| Q2 2025 | 5.10% |
| Q1 2025 | 0.64% |
| Q4 2024 | 3.47% |
| Q3 2024 | 20.15% |
| Q2 2024 | 7.03% |
| Q1 2024 | -6.87% |
| Q4 2023 | -5.99% |
| Q3 2023 | -6.15% |
| Q2 2023 | 5.91% |
| Q1 2023 | -6.68% |
| Q4 2022 | -2.01% |
| Q3 2022 | -5.25% |
| Q2 2022 | -5.85% |
| Q1 2022 | -7.08% |
| Q4 2021 | -3.45% |
| Q3 2021 | -2.84% |
| Q2 2021 | 8.86% |
| Q1 2021 | 281.36% |
| Q4 2020 | -19.33% |
| Q3 2020 | 13.99% |
| Q2 2020 | 44.94% |
| Q1 2020 | 6.04% |
| Q4 2019 | -13.81% |
| Q3 2019 | 13.47% |
| Q2 2019 | 5.40% |
| Q1 2019 | -13.69% |
| Q4 2018 | -9.57% |
| Q3 2018 | 30.32% |
| Q2 2018 | -8.59% |
| Q1 2018 | -8.46% |
| Q4 2017 | 16.61% |
| Q3 2017 | 13.21% |
| Q2 2017 | 1.09% |
| Q1 2017 | -0.69% |
| Q4 2016 | -2.13% |
| Q3 2016 | -4.62% |
| Q2 2016 | -7.12% |
| Q1 2016 | 7043.19% |